Skip to main content
. 2017 Jun 1;33(6):583–589. doi: 10.1089/aid.2016.0141

Table 2.

Characteristics of KS in HIV+ Patients on First Hospital Admission with Active KS

  n (%)
ACTG staging
 Tumor
  0 29 (67)
  1 14 (33)
 Immune
  0 3 (7)
  1 40 (93)
 System
  0 11 (26)
  1 32 (74)
Location of KS
 Skin 32 (74)
 Lung 18 (42)
 GI 15 (35)
 Lymphatic 12 (28)
 Oral 9 (21)
 Liver, spleen, or kidney 3 (7)
 Bone 2 (5)
Number of organ systems involved
 1 14 (33)
 2 14 (33)
 3+ 15 (35)

ACTG, AIDS clinical trial group.